Updated 06:12 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,842.80 -1.12% CL 88.67 +0.12% BTC 64,299.33 +0.27%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,843 −1.12% BTC $64,299 +0.27% VIX 19.30 +3.21% latest tape · as of 06:12 UTC
BICX
BioCorRx Inc.
Healthcare · Medical Care Facilities · OID
$0.55
Close 2026-05-15
✓ ETHICAL PASS
LIMITED
Data Confidence: 43%
Analysis based on available data — additional metrics being sourced
Market Cap
$14.5M
Trailing P/E
—
Forward P/E
-7.86
Rev Growth
+59.0%
Profit Margin
0.0%
ROE
—
Analyst Target
—
Recommendation
NONE
About BioCorRx Inc.

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss management program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists. It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of opioid use disorder. The company licenses and distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. was founded in 2009 and is based in Anaheim, California.

Opportunity Summary
Passes all ethical screens. Ranks better than 81% of screened stocks.
Ethical Screen
Business ActivityPASS
Debt Ratio (0.24%)PASS
Cash Ratio (0.02%)PASS
Receivables Ratio (0.00%)PASS
Revenue Ratio (0.00%)PASS
OverallPASS
Score Ethical: 90.3
Score Valuation: 33.0
Score Quality: 40.0
Score Combined: 36.1
· Tier: FAIR VALUE

Full Analysis

Opportunity scores, earnings history, insider transactions, institutional holders, analyst consensus, and more.

Unlock with Membership
Opportunity Scores
Valuation50.0
Quality50.0
Cash Flow50.0
Moat50.0
Balance Sheet100.0
Debt Purity27.1
Liquid Purity95.2
Rev Purity100.0
Compliance68.6
Tier: BRONZE · Score: 51.8 · Rank: #1446
Earnings History (Last 8 Quarters)
DateEPS Est.Reported EPSSurprise %
2025-11-14-0.06-0.11-83.3%
2015-11-16—Pending--
Quarterly Financials
PeriodRevenueNet IncomeEBITDAGross ProfitOp. IncomeEPS
2026-03-31$214.5K-$831.2K-$671.7K$189.4K-$587.0K-0.03
2025-12-31-$151.1K$552.6K-$398.0K$185.9K$466.3K—
2025-09-30$635.2K-$1.9M-$501.2K$276.4K-$1.1M-0.11
2025-06-30$178.2K-$1.2M-$1.1M$178.2K-$1.3M-0.07
2025-03-31$134.9K-$841.4K-$569.6K$134.9K-$524.0K-0.06
2024-12-31——————
Insider Transactions
DateNameRoleSharesValue
2024-12-31LUCIDO LOUIS CHARLESPresident1,428,647--
2024-12-31FELIX LOURDESChief Executive Officer752,979--
2024-06-28LUCIDO LOUIS CHARLESPresident44,220--
2024-06-28INGARGIOLA LUISADirector15,770--
2024-06-28FELIX LOURDESChief Executive Officer10,204--
2024-05-31LUCIDO LOUIS CHARLESPresident22,831--
Top Institutional Holders
No institutional holder data.
Additional Fundamentals
Enterprise Value
$13.4M
Price/Book
-1.01
Beta
0.173
Total Revenue (TTM)
$797.2K
Total Debt
$2.2M
Quantitative Grade

A single score combining all analytical layers below. A is strongest, D is weakest.

C
Quant Score
46.6
Risk Grade
—
Layers
7
Quality: HIGH_VOL,LOW_LIQUIDITY,HMM_CRISIS
Risk Profile

How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.

VaR 95%
-25.2%
worst expected daily loss, 19 in 20 days
CVaR 95%
-41.5%
avg loss on the worst 5% of days
Annual Volatility
—
Sortino Ratio
-0.12
above 1.0 is good
Max Drawdown
-79.6%
Worst Day
—
Forward Outlook

Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.

30d Prob Up
—
90d Prob Up
—
Median Return 30d
—
Liquidity Score
35
Liquidity Grade
LOW
Trend & Momentum

What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?

Kalman Trend
—
Trend Strength
—
Momentum Signal
—
HMM Regime
—
RSI Signal
—
Technical Signals

Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.

MA Crossover
GOLDEN_CROSS
Bollinger Position
UPPER_HALF
Beta
—
Relative Volume
1.7x
Short Interest
—
Financial Health

Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.

Altman Z-Score
—
—
below 1.81 = distress zone
Piotroski F-Score
—
Earnings Beat Rate
0.0%
Earnings Consistency
—
Correlations

These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.

Most Correlated
TickerCorrelation
KDK0.234
IDT0.191
IBKR0.181
MNST0.177
BOUBYAN.KW0.174
Inverse Correlated
TickerCorrelation
RIBT-0.178
4018.SR-0.175
ATC.KW-0.142
LPTVQ-0.138
DHTI-0.134
Seasonality

Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.

Best Day
Wednesday
Worst Day
Monday
Best Month
Oct
Worst Month
Aug
Fri-Mon Effect
3.4913017143075997
Momentum Rankings

How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.

1M Return
-6.9%
3M Return
+2.4%
6M Return
-5.2%
12M Return
+18.4%
Momentum Rank
#2905
Momentum Signal
FLAT
Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.